Quest Diagnostics Stock: Is Wall Street Bullish or Bearish?
finance.yahoo.com · 2026-08-25
While Quest Diagnostics has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.
TickrTrends take: Quest Diagnostics operates in the Healthcare sector and is currently assessed as overvalued according to TickrTrends' derived valuation metrics. Given this overvalued status, investors focused on valuation should monitor whether Wall Street's sentiment toward the stock reflects concerns about its current pricing, or conversely, whether bullish analyst views might indicate confidence that the company can justify its valuation through future performance. The divergence between valuation assessment and analyst sentiment could signal either a potential correction risk or an opportunity for those with conviction in the company's growth trajectory.
Read the full story at finance.yahoo.com →
Is DGX undervalued? See TickrTrends' fair value analysis →